Literature DB >> 15809432

Conformational variability of matrix metalloproteinases: beyond a single 3D structure.

Ivano Bertini1, Vito Calderone, Marta Cosenza, Marco Fragai, Yong-Min Lee, Claudio Luchinat, Stefano Mangani, Beatrice Terni, Paola Turano.   

Abstract

The structures of the catalytic domain of matrix metalloproteinase 12 in the presence of acetohydroxamic acid and N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid have been solved by x-ray diffraction in the crystalline state at 1.0 and 1.3-A resolution, respectively, and compared with the previously published x-ray structure at 1.2-A resolution of the adduct with batimastat. The structure of the N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid adduct has been solved by NMR in solution. The three x-ray structures and the solution structure are similar but not identical to one another, the differences being sizably higher in the loops. We propose that many of the loops show a dynamical behavior in solution on a variety of time scales. Different conformations of some flexible regions of the protein can be observed as "frozen" in different crystalline environments. The mobility in solution studied by NMR reveals conformational equilibria in accessible time scales, i.e., from 10(-5) s to ms and more. Averaging of some residual dipolar couplings is consistent with further motions down to 10(-9) s. Finally, local thermal motions of each frozen conformation in the crystalline state at 100 K correlate well with local motions on the picosecond time scale. Flexibility/conformational heterogeneity in crucial parts of the catalytic domain is a rule rather than an exception in matrix metalloproteinases, and its extent may be underestimated by inspection of one x-ray structure. Backbone flexibility may play a role in the difficulties encountered in the design of selective inhibitors, whereas it may be a requisite for substrate binding and broad substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809432      PMCID: PMC556229          DOI: 10.1073/pnas.0407106102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Matrix metalloprotease inhibitors: design from structure.

Authors:  N Borkakoti
Journal:  Biochem Soc Trans       Date:  2004-02       Impact factor: 5.407

3.  X-ray structures of binary and ternary enzyme-product-inhibitor complexes of matrix metalloproteinases.

Authors:  Ivano Bertini; Vito Calderone; Marco Fragai; Claudio Luchinat; Stefano Mangani; Beatrice Terni
Journal:  Angew Chem Int Ed Engl       Date:  2003-06-16       Impact factor: 15.336

4.  Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.

Authors:  Y C Li; X Zhang; R Melton; V Ganu; N C Gonnella
Journal:  Biochemistry       Date:  1998-10-06       Impact factor: 3.162

5.  High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.

Authors:  F J Moy; P K Chanda; S Cosmi; M R Pisano; C Urbano; J Wilhelm; R Powers
Journal:  Biochemistry       Date:  1998-02-10       Impact factor: 3.162

6.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

Review 7.  Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.

Authors:  L Steinman
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

8.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

9.  Crystal structure of the catalytic domain of human matrix metalloproteinase 10.

Authors:  I Bertini; V Calderone; M Fragai; C Luchinat; S Mangani; B Terni
Journal:  J Mol Biol       Date:  2004-02-20       Impact factor: 5.469

10.  The NMR structure of the inhibited catalytic domain of human stromelysin-1.

Authors:  P R Gooley; J F O'Connell; A I Marcy; G C Cuca; S P Salowe; B L Bush; J D Hermes; C K Esser; W K Hagmann; J P Springer
Journal:  Nat Struct Biol       Date:  1994-02
View more
  37 in total

1.  Probing water-protein contacts in a MMP-12/CGS27023A complex by nuclear magnetic resonance spectroscopy.

Authors:  Helena Kovacs; Tatiana Agback; Johan Isaksson
Journal:  J Biomol NMR       Date:  2012-04-15       Impact factor: 2.835

2.  Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3.

Authors:  Xiangyang Liang; A Arunima; Yingchu Zhao; Rajagopalan Bhaskaran; Anuradha Shende; Todd S Byrne; Jeremy Fleeks; Mark O Palmier; Steven R Van Doren
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

3.  Ramachandran analysis of conserved glycyl residues in homologous proteins of known structure.

Authors:  Balasubramanian Lakshmi; Chandrasekaran Sinduja; Govind Archunan; Narayanaswamy Srinivasan
Journal:  Protein Sci       Date:  2014-04-22       Impact factor: 6.725

4.  Heme-peptide/protein ions and phosphorous ligands: search for site-specific addition reactions.

Authors:  Maria Elisa Crestoni; Simonetta Fornarini
Journal:  J Biol Inorg Chem       Date:  2006-08-31       Impact factor: 3.358

Review 5.  Matrix metalloproteases: underutilized targets for drug delivery.

Authors:  Deepali G Vartak; Richard A Gemeinhart
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

6.  Rapid determination of enzyme kinetics from fluorescence: overcoming the inner filter effect.

Authors:  Mark O Palmier; Steven R Van Doren
Journal:  Anal Biochem       Date:  2007-07-18       Impact factor: 3.365

Review 7.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

8.  Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors.

Authors:  Luis A Alcaraz; Lucia Banci; Ivano Bertini; Francesca Cantini; Antonio Donaire; Leonardo Gonnelli
Journal:  J Biol Inorg Chem       Date:  2007-08-21       Impact factor: 3.358

9.  Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Nusayba A Bagegni; Xiangyang Liang; Steven R Van Doren
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

10.  Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.

Authors:  Thomas Bordenave; Marion Helle; Fabrice Beau; Dimitris Georgiadis; Livia Tepshi; Mylène Bernes; Yunpeng Ye; Laure Levenez; Enora Poquet; Hervé Nozach; Mahmoud Razavian; Jakub Toczek; Enrico A Stura; Vincent Dive; Mehran M Sadeghi; Laurent Devel
Journal:  Bioconjug Chem       Date:  2016-09-14       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.